Catalyst Pharmaceuticals, Inc. - stock earnings
CPRX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 34.8 million USD | 110.6 million USD |
2023Q3 | -30.8 million USD | 102.7 million USD |
2023Q2 | 37.8 million USD | 99.6 million USD |
2023Q1 | 29.6 million USD | 85.4 million USD |
2022Q4 | 25.5 million USD | 60.8 million USD |
2022Q3 | 22.7 million USD | 57.2 million USD |
2022Q2 | 21.6 million USD | 53.1 million USD |
2022Q1 | 13.2 million USD | 43.1 million USD |
2021Q4 | 9.3 million USD | 38.3 million USD |
2021Q3 | 10.3 million USD | 36.0 million USD |
2021Q2 | 12.2 million USD | 36.4 million USD |
2021Q1 | 7.7 million USD | 30.2 million USD |
2020Q4 | 11.4 million USD | 31.0 million USD |
2020Q3 | 43.3 million USD | 29.3 million USD |
2020Q2 | 9.8 million USD | 29.6 million USD |
2020Q1 | 10.4 million USD | 29.1 million USD |
2019Q4 | 7.9 million USD | 30.1 million USD |
2019Q3 | 13.6 million USD | 30.9 million USD |
2019Q2 | 11.0 million USD | 28.8 million USD |
2019Q1 | -644503 USD | 12.4 million USD |
2018Q4 | -14.5 million USD | 500000 USD |
2018Q3 | -7.8 million USD | ? USD |
2018Q2 | -6.0 million USD | ? USD |
2018Q1 | -5.7 million USD | ? USD |
2017Q4 | -5.4 million USD | ? USD |
2017Q3 | -4.2 million USD | ? USD |
2017Q2 | -3.9 million USD | ? USD |
2017Q1 | -5.0 million USD | ? USD |
2016Q4 | -4.2 million USD | ? USD |
2016Q3 | -4.0 million USD | ? USD |
2016Q2 | -4.6 million USD | ? USD |
2016Q1 | -5.4 million USD | ? USD |
2015Q4 | -5.8 million USD | ? USD |
2015Q3 | -4.4 million USD | ? USD |
2015Q2 | -4.6 million USD | ? USD |
2015Q1 | -5.4 million USD | ? USD |
2014Q4 | -3.5 million USD | ? USD |
2014Q3 | -5.0 million USD | ? USD |
2014Q2 | -3.2 million USD | ? USD |
2014Q1 | -3.8 million USD | ? USD |
2013Q4 | -1.4 million USD | ? USD |
2013Q3 | -5.9 million USD | ? USD |
2013Q2 | -3.1 million USD | ? USD |
2013Q1 | -76585 USD | ? USD |
2012Q4 | -76585 USD | ? USD |
2012Q3 | -2.6 million USD | ? USD |
2012Q2 | -289080 USD | ? USD |
2012Q1 | -1.1 million USD | ? USD |
2011Q4 | -2.4 million USD | ? USD |
2011Q3 | -1.1 million USD | ? USD |
2011Q2 | -1.4 million USD | ? USD |
2011Q1 | -1.5 million USD | 488958 USD |
2010Q4 | -728754 USD | 488958 USD |
2010Q3 | -903985 USD | ? USD |
2010Q2 | -1.3 million USD | ? USD |
2010Q1 | -1.0 million USD | ? USD |
2009Q4 | -1.2 million USD | ? USD |
2009Q3 | -1.3 million USD | ? USD |
2009Q2 | -1.8 million USD | ? USD |
2009Q1 | -3.0 million USD | -301325 USD |
2008Q4 | -3.7 million USD | ? USD |
2008Q3 | -2.9 million USD | ? USD |
2008Q2 | -2.4 million USD | ? USD |
2008Q1 | -1.6 million USD | -179979 USD |
2007Q4 | -944938 USD | ? USD |
2007Q3 | -734347 USD | ? USD |
2007Q2 | -1.2 million USD | ? USD |
2007Q1 | -741241 USD | ? USD |
2006Q4 | -741241 USD | ? USD |
2006Q3 | -1.3 million USD | ? USD |
2006Q2 | -333413 USD | ? USD |
2006Q1 | -333413 USD | ? USD |
2005Q4 | -1.3 million USD | ? USD |
2005Q3 | -241854 USD | ? USD |
2005Q2 | -660836 USD | ? USD |
2005Q1 | -660836 USD | ? USD |
2004Q4 | -134955 USD | ? USD |
2004Q3 | -134955 USD | ? USD |
2004Q2 | -134955 USD | ? USD |
2004Q1 | -134955 USD | ? USD |
CPRX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 71.4 million USD | 398.2 million USD |
2022 | 83.1 million USD | 214.2 million USD |
2021 | 39.5 million USD | 140.8 million USD |
2020 | 75.0 million USD | 119.1 million USD |
2019 | 31.9 million USD | 102.3 million USD |
2018 | -34.0 million USD | 500000 USD |
2017 | -18.4 million USD | ? USD |
2016 | -18.1 million USD | ? USD |
2015 | -20.2 million USD | ? USD |
2014 | -15.5 million USD | ? USD |
2013 | -12.2 million USD | ? USD |
2012 | -4.1 million USD | ? USD |
2011 | -6.4 million USD | ? USD |
2010 | -4.0 million USD | 488958 USD |
2009 | -7.2 million USD | ? USD |
2008 | -10.6 million USD | ? USD |
2007 | -4.1 million USD | ? USD |
2006 | -2.7 million USD | ? USD |
2005 | -1.8 million USD | ? USD |
2004 | -539820 USD | ? USD |
2003 | -428615 USD | ? USD |
2002 | -255945 USD | ? USD |
CPRX
Price: $14.72
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.63 USD
P/E Ratio: 25.45
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.7 million
Ebitda: -4.3 millionMarket Capitalization: 1.8 billion